ID
28152
Beskrivning
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Investigational product
Nyckelord
Versioner (4)
- 2017-09-21 2017-09-21 -
- 2017-10-13 2017-10-13 -
- 2017-10-23 2017-10-23 -
- 2017-12-22 2017-12-22 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
22 december 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Investigational product GSK study Chronic Coronary Heart Disease NCT00799903
Investigational product GSK study Chronic Coronary Heart Disease NCT00799903
Beskrivning
Investigational product discontinuation
Beskrivning
investigational product stopped permanently
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0457454
Beskrivning
Select "Protocol deviation" if none of the other primary reasons are appropriate. Select "Decision by subject or proxy" if none of the other primary reasons are appropriate. In case of "Adverse Event", record details on the Non-Serious Adverse Events or Serious Adverse Events forms as appropriate. Check all that apply. If none, select "No Subreasons".
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0392360
- UMLS CUI [1,2]
- C0013230
- UMLS CUI [1,3]
- C0457454
Beskrivning
Record details on the Non-Serious Adverse Events or Serious Adverse Events forms as appropriate. Check all that apply. If none, select "No Subreasons":
Datatyp
boolean
Alias
- UMLS CUI [1]
- C2699517
Beskrivning
Adverse event MACE
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C1516728
- UMLS CUI [1,2]
- C2826934
Beskrivning
Select this reason if none of the other primary reasons are appropriate.
Datatyp
text
Alias
- UMLS CUI [1]
- C1705236
Beskrivning
Select this reason if none of the other primary reasons are appropriate.
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C0679006
Beskrivning
Sponsor terminated study treatment specification
Datatyp
text
Alias
- UMLS CUI [1]
- C1710224
Beskrivning
Investigator site closed specification
Datatyp
text
Alias
- UMLS CUI [1]
- C2348235
Beskrivning
Post-IP Follow-up status
Beskrivning
Select type [1] if telephone follow-up was accepted by subject. Please complete TELE visit form for each contact. In case of type [2], please complete THIRD PARTY visit form for each contact. In case of type [3], please complete CONC form within EOS visit.
Datatyp
integer
Alias
- UMLS CUI [1,1]
- C0589121
- UMLS CUI [1,2]
- C0205272
Beskrivning
Fill in in case "Post-IP Phone Follow-up With Subject" or "Post-IP Follow-up through designated third party" has been selected.
Datatyp
text
Alias
- UMLS CUI [1]
- C3476109
Beskrivning
Contact frequency other
Datatyp
text
Alias
- UMLS CUI [1]
- C0337611
Beskrivning
Authorization status
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0680281
- UMLS CUI [1,2]
- C0018724
Similar models
Investigational product GSK study Chronic Coronary Heart Disease NCT00799903
C0011008 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,3])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C2826934 (UMLS CUI [1,2])
C0679006 (UMLS CUI [1,2])
C0205272 (UMLS CUI [1,2])
C0018724 (UMLS CUI [1,2])